Thomas A. Mace

Thomas A. Mace's research focuses on pancreatic cancer, particularly how the tumor microenvironment and immune system interact to affect disease progression and treatment response. Much of the work examines immune checkpoint inhibitor therapies, cancer-related muscle wasting (cachexia), and factors like inflammation, obesity, and immune signaling molecules (such as CD200 and IL-6) that influence tumor growth and immunotherapy effectiveness. The lab also explores diet and lifestyle factors, such as physical activity and food-based interventions, in relation to inflammation and cancer risk.

Publication output was relatively steady at 5-13 papers per year from 2017-2022, then spiked sharply to 60 in 2023 before settling back to a still-elevated pace of 9-13 papers per year in 2024-2026.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026